Pharmaceutical Industry China

1
Pharmaceutical Industry China
One-Stop Shop for Business Information
2
Summary
Pharmaceutical Industry China Q3 2013
Cutting-Edge Analysis of Multinational and
Chinese Biopharma Companies, Industry Trends,
Environment, Regulation, Market Drivers,
Restraints, Opportunities Challenges provides
you with a detailed investigation of the market
size, segmentation, key players, SWOT analysis,
influential Government policies, and business and
economic environments. The report is supported by
over 196 tables figures within 145 pages. The
Chinese biopharmaceutical market is presented as
follows By Company (e.g., AMOYTOP BIOTECH,
BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN,
SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH,
ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By
Therapeutic Area (e.g., Anti-infective, Cancer,
Diabetes, Dementia, Depression)
3
A wealth of financial information is provided
including Company financials, sales revenue
figures historical to Q22013 China GDP,
economic growth, export (bulk drug, formulations)
figures Indian health expenditure as a function
of GDP Growth change figures of emerging and
developing countries (India, Russia, China,
Brazil) Economic growth figures of advanced
economies (USA, UK, Germany, France, Italy,
Spain, Japan, Canada) Projected figures of
strategic emerging industry GDP percentage
contribution
4
SWOT, Economic and Business Environment specifics
include Key strengths, weaknesses and threats
influencing leading player position within the
market Top Five Contract Pharmaceutical Export
Markets of China Major players within Chinas
leading therapeutic markets (e.g., cancer,
allergy, liver disease) Multinational
penetration into the Chinese Pharma Market
Comprehensive product portfolios, RD activity
and pipeline therapeutics 
5
MA activity and future strategies of top
Chinese pharmacos Economic indicators, trade
policy, merchandise and commercial trade
statistics Gross Domestic Product of China,
historic and projection analysis Chinese
economic outlook in comparison to advanced
economies  Three Tier Pharmerging Markets
with Potential for Significant Growth 
Prescription drug sales distribution channels in
China Major biogeneric products in China
6
Table of Contents

1. Summary 
2. Chronic Disease Prevalence Statistics
3.  Business Environment
4. Chinese Pharmaceutical Market
5. Government and Regulation Environment 
6.  China Third Largest Pharma Market 2012
7. Global Pharmaceutical Companies Interest in China
8. Chinese Pharmaceutical Companies 
9. Drivers, Restraints, Challenges and Opportunity
   Analysis

7
Related Reports

• Pharmaceutical Market India A Comprehensive
  Industry Analysis
• Pharmaceutical Sector in India 2013
• The Engineered T-Cell Receptor in Fusion
  Proteins, Antibodies Cells Emerging
  Opportunities for the Biopharmaceutical
  Industry
• Excipients in Pharmaceuticals
• World OTC Pharmaceutical Market 2013-2023

8
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and
  benchmarks.
• http//www.bharatbook.com/customResearch.asp

9
For More Information You Can Visit

• http//www.bharatbook.com/healthcare-market-resear
  ch-reports/pharmaceutical-industry-china.html

Request Sample Pages
Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Call UK
44 7405 208461 For Live Chat -
http//bit.ly/19m3TU4
Follow/Like Us on-